Environmental Estrogen Induced Epigenetic Alteration of Uterine Stem Cells
环境雌激素诱导子宫干细胞的表观遗传改变
基本信息
- 批准号:8388459
- 负责人:
- 金额:$ 41.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-10 至 2017-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAffectAnimalsBreastCell ProliferationCell physiologyCellsChIP-seqChromatinDataDefectDiethylstilbestrolDiseaseDoseEndocrine DisruptorsEndocrine disruptionEndometrialEndometrial CarcinomaEndometriumEnvironmental EstrogenEpigenetic ProcessEstradiolEstrogen ReceptorsEstrogensEstrusEthinyl EstradiolExposure toExtracellular MatrixFemaleGene ExpressionGenesGenomeGrowthHumanIn VitroIncidenceInvadedKnowledgeLeadLifeMeasuresMediatingMenstrual cycleMenstruationMethylationModelingMolecularMusNatural regenerationPerinatal ExposurePhenotypePopulationPrecipitationPreventiveProliferatingRelative (related person)Replacement TherapyResearch PersonnelResponse ElementsRodentRoleSignal TransductionStem cellsTestingTherapeuticTissuesTransplantationUterine DiseasesUterusWomanbasebisphenol Abisulfitecell growthdesigndevelopmental diseaseendometriosisestrogenic activityexposed human populationfetalin vivoin vivo Modelprogenitorprogramsreproductiveresponsexenoestrogen
项目摘要
DESCRIPTION (provided by applicant): In humans, exposure to xenoestrogens such as diethylstilbestrol (DES) and bisphenol A (BPA) has been associated with developmental disorders of the female reproductive tract. The investigators have previously shown that fetal exposure to these agents alters the methylation of estrogen response elements (EREs) in the endometrium. The change in ERE methylation results in altered ERE occupancy by estrogen receptor (ER) in vivo and altered gene expression in response to estrogens throughout life. The uterine endometrium is replaced in each menstrual cycle or estrus cycle in humans or rodents, respectively. The investigators were the first to identify the stem cells that regenerate this tisse. As the epigenetic changes in estrogen response persist in the adult, they are likely to be encoded in the stem cells that regenerate the endometrium in each reproductive cycle. The investigators hypothesize that xenoestrogen exposure affects methylation of multiple EREs in uterine stem cells leading to altered estrogen sensitivity as an adult. To test this hypothesis the
investigators will determine the extent of uterine ERE methylation in the entire genome after DES or BPA exposure as well as the effect of exposure to these agents on endometrial stem cell growth and estrogen response in vitro and in vivo. The specific aims include 1) the use of chromatin precipitation, massively parallel sequencing and bisulfite sequencing to determine if exposure leads to preferential methylation of multiple EREs and if this occurs in uterine stem cells; 2) determine if exposure leads to altered endometrial stem cell estrogen response in vitro; and 3) use of an in vivo model to determine if endometrial stem cells from exposed animals are more prone to endometriosis or endometrial cancer. These studies will test the hypothesis that methylation of EREs in uterine stem cells and resultant altered estrogen responsiveness will lead to an increased incidence of estrogen mediated disorders, thus providing an epigenetic mechanism for reproductive tract disease associated with xenoestrogen exposure. This model explains how a weak estrogen results in an estrogenic response disproportionate to its intrinsic estrogenic activity and how this epigenetic signal persists despite loss of endometrium in each reproductive cycle due to altered methylation in endometrial stem cells.
PUBLIC HEALTH RELEVANCE: Stem cells regenerate the endometrial lining of the uterus which is shed with each menstrual period. These studies will determine if the effects of fetal environmental estrogen exposure are epigenetically encoded in the endometrial stem cells. Knowledge of the molecular and cellular mechanisms that underlie the effects of environmental estrogen exposure will allow the design of preventive and therapeutic strategies.
描述(由申请人提供):在人类中,暴露于异种雌激素,例如二乙基苯甲酸酯(DES)和双酚A(BPA)与女性生殖道的发育障碍有关。研究人员先前已经表明,胎儿暴露于这些药物会改变子宫内膜中雌激素反应元件(ERE)的甲基化。 ERE甲基化的变化导致体内雌激素受体(ER)的占用率改变,并改变了基因表达对雌激素的响应。子宫内膜子宫内膜在每个月经周期或人类或啮齿动物中分别被替换。研究人员是第一个识别再生该提示的干细胞的人。随着成年人雌激素反应的表观遗传变化持续存在,它们可能在每个生殖周期中再生子宫内膜的干细胞中编码。研究人员假设异源性暴露会影响子宫干细胞中多个ERE的甲基化,从而导致雌激素敏感性改变。为了检验这一假设
研究人员将在DES或BPA暴露后确定整个基因组中的子宫甲基化程度,以及暴露于这些药物对子宫内膜干细胞生长和体内雌激素反应的影响。具体目的包括1)使用染色质沉淀,大规模平行测序和亚硫酸盐测序,以确定暴露是否导致多个ERE的优先甲基化以及子宫干细胞中是否发生这种情况; 2)确定暴露在体外是否导致子宫内膜干细胞雌激素反应改变; 3)使用体内模型来确定来自暴露动物的子宫内膜干细胞是否更容易发生子宫内膜异位症或子宫内膜癌。这些研究将检验以下假设:子宫干细胞中ERE的甲基化以及雌激素反应的改变将导致雌激素介导的疾病的发生率增加,从而提供了一种与甲烯雌激素相关的生殖道疾病的表观遗传机制。 该模型解释了弱雌激素如何导致雌激素反应与其内在的雌激素活性不成比例,以及该表观遗传信号如何持续,尽管由于子宫内膜干细胞中甲基化的改变,每个生殖循环中子宫内膜的丧失。
公共卫生相关性:干细胞再生子宫的子宫内膜衬里,每个月经期都会脱落。这些研究将确定胎儿环境雌激素暴露的影响是否在子宫内膜干细胞中表观遗传编码。了解环境雌激素暴露影响的分子和细胞机制的知识将允许设计预防和治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hugh Smith Taylor其他文献
Hugh Smith Taylor的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hugh Smith Taylor', 18)}}的其他基金
Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (Pregnant) - Application 1/4
使用 GnRH 拮抗剂治疗子宫内膜异位症女性的 IVF 前治疗 - 前瞻性双盲安慰剂对照试验(怀孕) - 应用 1/4
- 批准号:
10251323 - 财政年份:2019
- 资助金额:
$ 41.51万 - 项目类别:
Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4
生殖医学协作联盟:一项 EGCG 改善子宫肌瘤女性生育能力的随机安慰剂对照试验 - 应用 4/4
- 批准号:
10477364 - 财政年份:2019
- 资助金额:
$ 41.51万 - 项目类别:
Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4
生殖医学协作联盟:一项 EGCG 改善子宫肌瘤女性生育能力的随机安慰剂对照试验 - 应用 4/4
- 批准号:
10251309 - 财政年份:2019
- 资助金额:
$ 41.51万 - 项目类别:
Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (Pregnant) - Application 1/4
使用 GnRH 拮抗剂治疗子宫内膜异位症女性的 IVF 前治疗 - 前瞻性双盲安慰剂对照试验(怀孕) - 应用 1/4
- 批准号:
10478236 - 财政年份:2019
- 资助金额:
$ 41.51万 - 项目类别:
Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (Pregnant) - Application 1/4
使用 GnRH 拮抗剂治疗子宫内膜异位症女性的 IVF 前治疗 - 前瞻性双盲安慰剂对照试验(怀孕) - 应用 1/4
- 批准号:
10700871 - 财政年份:2019
- 资助金额:
$ 41.51万 - 项目类别:
Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4
生殖医学协作联盟:一项 EGCG 改善子宫肌瘤女性生育能力的随机安慰剂对照试验 - 应用 4/4
- 批准号:
10704544 - 财政年份:2019
- 资助金额:
$ 41.51万 - 项目类别:
Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (Pregnant) - Application 1/4
使用 GnRH 拮抗剂治疗子宫内膜异位症女性的 IVF 前治疗 - 前瞻性双盲安慰剂对照试验(怀孕) - 应用 1/4
- 批准号:
10025594 - 财政年份:2019
- 资助金额:
$ 41.51万 - 项目类别:
Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4
生殖医学协作联盟:一项 EGCG 改善子宫肌瘤女性生育能力的随机安慰剂对照试验 - 应用 4/4
- 批准号:
10025595 - 财政年份:2019
- 资助金额:
$ 41.51万 - 项目类别:
Environmental Estrogen Induced Epigenetic Alteration of Uterine Stem Cells
环境雌激素诱导子宫干细胞的表观遗传改变
- 批准号:
8869016 - 财政年份:2012
- 资助金额:
$ 41.51万 - 项目类别:
Environmental Estrogen Induced Epigenetic Alteration of Uterine Stem Cells
环境雌激素诱导子宫干细胞的表观遗传改变
- 批准号:
8528662 - 财政年份:2012
- 资助金额:
$ 41.51万 - 项目类别:
相似国自然基金
多种动物活动对高寒草甸生态系统性状的影响
- 批准号:42301054
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
大型野生动物对秦岭山地森林林下植物物种组成和多样性的影响及作用机制
- 批准号:32371605
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
闸坝建设对河口大型底栖动物功能与栖息地演变的影响-以粤西鉴江口为例
- 批准号:42306159
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
降水变化下土壤动物协作效应对土壤有机质形成过程的影响
- 批准号:42307409
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
城市化对土壤动物宿主-寄生虫关系的影响机制研究
- 批准号:32301430
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 41.51万 - 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
- 批准号:
10465010 - 财政年份:2023
- 资助金额:
$ 41.51万 - 项目类别:
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 41.51万 - 项目类别:
Maternal inflammation in relation to offspring epigenetic aging and neurodevelopment
与后代表观遗传衰老和神经发育相关的母体炎症
- 批准号:
10637981 - 财政年份:2023
- 资助金额:
$ 41.51万 - 项目类别: